ALYSIA AUGUST: Open Payments
NPI 1700508082 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,704 in 91 payments from 18 companies in 2025. Trend: 2023 $778 · 2024 $1,995 · 2025 $1,704
Food & beverage: $1,609Education: $95
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $248 |
| PFIZER INC. | 15 | $194 |
| Lilly USA, LLC | 8 | $167 |
| Regeneron Healthcare Solutions, Inc. | 6 | $150 |
| Galderma Laboratories, L.P. | 14 | $145 |
| Janssen Biotech, Inc. | 2 | $124 |
| GENZYME CORPORATION | 3 | $114 |
| Botanix SB Inc | 5 | $104 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $99 |
| Novartis Pharmaceuticals Corporation | 3 | $93 |
Products named: DUPIXENT, CIBINQO, RINVOQ, NEMLUVIO, TREMFYA, SOFDRA, TALTZ, SKYRIZI.
Industry payments across GA — which companies pay providers there.
